mafosfamide has been researched along with mechlorethamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Górski, A; Rychlik, G; Wasik, M | 1 |
| Broekema, GJ; Dirven, MW; Hählen, K; Heyenbrok, MW; Huismans, DR; Loonen, AH; Pieters, R; Veerman, AJ | 1 |
| Campanini, E; Fogli, M; Fortuna, A; Lemoli, RM; Mangianti, S; Motta, MR; Ratta, M; Rizzi, S; Tura, S | 1 |
3 other study(ies) available for mafosfamide and mechlorethamine
| Article | Year |
|---|---|
The effect of cyclophosphamide derivatives on cellular cytotoxicity (NK, ADCC) in vitro.
Topics: Aged; Animals; Antibody-Dependent Cell Cytotoxicity; Cyclophosphamide; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Mechlorethamine | 1990 |
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
Topics: Asparaginase; Cells, Cultured; Child; Coloring Agents; Culture Media; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Mechlorethamine; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tetrazolium Salts; Thiazoles; Thioguanine; Vincristine | 1990 |
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cyclophosphamide; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Neoplasm, Residual; Tumor Cells, Cultured | 1997 |